Caxton Associates LLP Invests $588,000 in Huron Consulting Group Inc. $HURN

Key Points

• Caxton Associates LLP acquired a new position in Huron Consulting Group, purchasing 4,097 shares valued at approximately $588,000 during the 1st quarter.
• Huron Consulting Group reported $1.89 EPS for the last quarter, exceeding the consensus estimate of $1.79, while its revenue increased by 8.3% year-over-year.
• Recent analyst ratings vary, with some upgrades, like Barrington Research raising the price target from $173.00 to $176.00, while others, such as Wall Street Zen, downgraded the stock from "buy" to "hold."

Caxton Associates LLP bought a new position in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 4,097 shares of the business services provider's stock, valued at approximately $588,000.

Several other large investors have also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. increased its holdings in Huron Consulting Group by 10.0% in the 4th quarter. Ameriprise Financial Inc. now owns 57,273 shares of the business services provider's stock valued at $7,117,000 after buying an additional 5,187 shares during the period. BNP Paribas Financial Markets boosted its position in shares of Huron Consulting Group by 4.5% during the 4th quarter. BNP Paribas Financial Markets now owns 12,855 shares of the business services provider's stock valued at $1,597,000 after acquiring an additional 554 shares in the last quarter. Cetera Investment Advisers increased its stake in Huron Consulting Group by 7.6% in the fourth quarter. Cetera Investment Advisers now owns 3,021 shares of the business services provider's stock valued at $375,000 after acquiring an additional 213 shares during the period. Gotham Asset Management LLC acquired a new position in Huron Consulting Group in the fourth quarter worth about $213,000. Finally, Lazard Asset Management LLC raised its position in Huron Consulting Group by 9.6% in the fourth quarter. Lazard Asset Management LLC now owns 13,260 shares of the business services provider's stock worth $1,647,000 after purchasing an additional 1,165 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company's stock.

Huron Consulting Group Stock Performance

Shares of HURN stock traded up $0.39 on Wednesday, hitting $142.00. 21,732 shares of the stock were exchanged, compared to its average volume of 202,101. Huron Consulting Group Inc. has a one year low of $102.94 and a one year high of $155.00. The firm's 50 day moving average is $134.75 and its two-hundred day moving average is $139.87. The firm has a market capitalization of $2.46 billion, a PE ratio of 24.78 and a beta of 0.32. The company has a current ratio of 1.99, a quick ratio of 1.99 and a debt-to-equity ratio of 1.35.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The business services provider reported $1.89 EPS for the quarter, beating the consensus estimate of $1.79 by $0.10. The firm had revenue of $402.50 million during the quarter, compared to the consensus estimate of $402.67 million. Huron Consulting Group had a net margin of 6.60% and a return on equity of 25.52%. The business's quarterly revenue was up 8.3% compared to the same quarter last year. During the same period last year, the firm earned $1.68 EPS. Huron Consulting Group has set its FY 2025 guidance at 7.300-7.70 EPS. Sell-side analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on HURN shares. Barrington Research upped their price objective on Huron Consulting Group from $173.00 to $176.00 and gave the company an "outperform" rating in a research note on Thursday, August 7th. Wall Street Zen lowered Huron Consulting Group from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Five research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $171.50.

Insider Activity at Huron Consulting Group

In other news, insider Kyle Featherstone sold 375 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $135.73, for a total value of $50,898.75. Following the transaction, the insider owned 1,311 shares in the company, valued at approximately $177,942.03. This represents a 22.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director James H. Roth sold 2,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $137.51, for a total transaction of $275,020.00. Following the completion of the sale, the director owned 41,304 shares in the company, valued at $5,679,713.04. This represents a 4.62% decrease in their position. The disclosure for this sale can be found here. Insiders sold 7,211 shares of company stock valued at $967,191 in the last three months. Corporate insiders own 2.15% of the company's stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.